About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

OPERA Database - Crohn's Protocol | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01720368

OPERA Database - Crohn's Protocol

The investigators believe that patients with Crohn's disease are able to report details of their own medical history accurately and record changes in clinical status effectively over time. Using an in...

Lead sponsor: Dartmouth-Hitchcock Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

Abbott

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults (over 18 years of age) with physician diagnosed Crohn's disease
•A current or past prescription of anti-TNF
•Access to medical record for validation of clinical information

Exclusion Criteria

•Unwilling or unable to provide informed consent for study participation
•Unable to access or use the internet
•Ulcerative colitis or IBD-U
•Illiterate or does not possess minimum level of literacy required to complete questionnaire

Related studies

RECRUITINGPhase 3

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184931 · Crohn's Disease

RECRUITINGPhase 3

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

NCT06100289 · Ulcerative Colitis, Crohn's Disease

RECRUITINGPhase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more

RECRUITINGPhase 4

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

NCT06180382 · Crohn's Disease

RECRUITINGEARLY Phase 1

A Clinical Study of SPH7854 Granules in Healthy Subjects.

NCT06483373 · Inflammatory Bowel Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 17, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment50

Start dateOct 2012

Last updatedAug 17, 2015

Condition

Inflammatory Bowel Disease Crohn's Disease

Locations shown

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions